2024
DOI: 10.1007/s10526-023-10236-z
|View full text |Cite
|
Sign up to set email alerts
|

Silage pathogens and biological control agents: effects, action mechanisms, challenges and prospects

Huifang Jiang,
Charles Obinwanne Okoye,
Yanfang Wu
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 89 publications
0
1
0
Order By: Relevance
“…Lactic acid bacteria that heterologously express OXDC may be used as potential probiotics for degrading intestinal oxalate to prevent calcium oxalate (CaOx) stone (Figure ). For example, Paul and his colleagues developed food-grade probiotic L. plantarum secreting OXDC using mobile genetic element Ll.LtrB and chromosomal integration, which is capable of degrading intestinal oxalate and preventing CaOx stone formation in experimental rats. , Wu et al found that Zn 2+ regulates human oxalate metabolism by manipulating oxalate decarboxylase to treat calcium oxalate stones and promoting Lactobacillus in the intestinal flora . More interesting is that Human Embryonic Kidney 293 (HEK293) cells expressing OXDC are capable of degrading oxalate protect cells from oxidative damage and serve as a therapeutic option for prevention of CaOx stone disease …”
Section: Application Of Oxalate Decarboxylasementioning
confidence: 99%
“…Lactic acid bacteria that heterologously express OXDC may be used as potential probiotics for degrading intestinal oxalate to prevent calcium oxalate (CaOx) stone (Figure ). For example, Paul and his colleagues developed food-grade probiotic L. plantarum secreting OXDC using mobile genetic element Ll.LtrB and chromosomal integration, which is capable of degrading intestinal oxalate and preventing CaOx stone formation in experimental rats. , Wu et al found that Zn 2+ regulates human oxalate metabolism by manipulating oxalate decarboxylase to treat calcium oxalate stones and promoting Lactobacillus in the intestinal flora . More interesting is that Human Embryonic Kidney 293 (HEK293) cells expressing OXDC are capable of degrading oxalate protect cells from oxidative damage and serve as a therapeutic option for prevention of CaOx stone disease …”
Section: Application Of Oxalate Decarboxylasementioning
confidence: 99%